Interactive Brokers Advertisement
Home > Boards > US OTC > Computers - Software >

Grey Cloak Tech (GRCK)

Add GRCK Price Alert      Hide Sticky   Hide Intro
Moderator: Papa Bear, Carjockey2, sjoseph, maz1978 , FollowTheProfits, dipANDrip
Search This Board: 
Last Post: 12/16/2017 8:49:45 PM - Followers: 174 - Board type: Free - Posts Today: 0

Social Media Links - Click Below
Image result for twitter iconImage result for facebook iconImage result for linkedin icon

Grey Cloak Tech Announces Q2 Results, Continues to Seek Acquisition Candidates


Las Vegas, Nevada (PRWEB) September 07, 2016

For the second quarter of 2016, revenues were $41,250 for the three months ended June 30, 2016, compared to $34,800 for the three months ended June 30, 2015, an increase of $6,450, or 19%. Revenues were $80,250 for the six months ended June 30, 2016, compared to $45,400 for the six months ended June 30, 2015, an increase of $34,850, or 77%. Net operating loss was $64,425 for the three months ended June 30, 2016, compared to $107,416 for the three months ended June 30, 2015, a decrease of $42,991. Net loss was $108,796 for the three months ended June 30, 2016, or $0.01 per share, compared to $107,388 for the three months ended June 30, 2015, or $0.01 per share, an increase of $1,408. The $0.01 loss per share is based on a total of 15,290,849 outstanding shares as of June 30 2016.

Grey Cloak's revenues were generated through sales of their debut product, Fraudlytic, which continues to serve key customers across a variety of sectors including telecom, retail, and the automotive industry. Fraudlytic was developed to combat the increasing threat of digital advertising fraud - also known as bot fraud or click fraud - which the Interactive Advertising Bureau (IAB) projects could cost unsuspecting advertisers $8.2 billion annually. More recently, research conducted by the World Federation of Advertisers (WFA) projected the cost could exceed $50 billion a year by 2025.

To stay ahead of the threat, Grey Cloak continues to improve upon their core product. Version 2.0 of the product was rolled out in early August. Updates to the Fraudlytic software included performance improvements and better data tracking.

"The company is excited about Fraudlytic's advancements, and we're looking forward to adding products to our portfolio that are able to leverage the Fraudlytic technology," says Fred Covely, CEO of Grey Cloak, "the company will continue to improve on its current click fraud detection software, develop other suites of software, and explore other software products through possible acquisitions."

Forward-Looking Statements

Safe Harbor Notice 
Certain statements contained herein are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Grey Cloak Tech Inc. cautions that statements, and assumptions made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates made by management. Actual results could differ materially from current projections or implied results. Grey Cloak Tech Inc. undertakes no obligation to revise these statements following the date of this news release.

For more information, visit

Read the full story at


Grey Cloak develops advanced software to overcome the most costly online security threats, including digital advertising fraud. Our mission is to revolutionize internet security by overcoming one threat at a time.
Image result for click fraud

Image result for click fraud Our debut cloud-based product, Fraudlytic, detects, tracks, and eliminates digital advertising fraud, a problem the Interactive Advertising Bureau (IAB) projects will cost unsuspecting advertisers $8.2 billion annually. As digital advertising is poised to overtake television advertising by 2019, according to PwC, the cost of online fraud threatens to grow exponentially. 

"Our mission is to revolutionize internet security by overcoming one threat at a time."



Fraudlytic™ is a cloud-based, secure platform that monitors internet traffic in real time, blocking malicious and false clicks, while allowing real consumers to view offers and buy.
The click-fraud phenomena is costing digital advertisers billions of dollars and to date there is only one way to stop it: effective detection and elimination software.
Grey Cloak Tech founders have deep roots in the digital marketing industry and observed this problem many years ago. Combining with internet security specialists and the best programmers in this field, Grey Cloak Tech set out to stop the malicious viruses (bots) that not only cause false clicks, but infect computers worldwide with other destructive elements.
Like a laser-guided weapon, Fraudlytic™ detects, analyzes, and destroys bots while allowing legitimate consumer traffic to click and view digital ads.


fraudlytic-bold_600x400 - Copy
Image result for click fraud



Impression Fraud: Click fraud is ever evolving via manipulations of impressions. Grey Shield applies state-of-the-art, ever evolving detection programming to swiftly analyze and prohibit:


Masked URLs
Cookie Hijacking
Device Hijacking
IP Spoofing
Domain ID Theft
Ad Stacking

Doorway Site Detection: Search engine “doorways” are artificial web pages that redirect visitors without their knowledge by cloaking their actual URLs. Grey Shield’s landing page auditor penetrates false doorways and permanently bars them from your potential customers.


Self Programmable SAAS solution: Reduce IT costs with Grey Shield’s easy-to-set-up campaigns that provide detailed reports based on users behavior or on the campaign level. It will tell you which marketing campaigns are effective and which are fraudulent so they can get a predictable ROI. You can either block the bad traffic so it never reaches your website or you can see it in the reporting and make your marketing decisions on future campaigns, phones, tablets, and laptops.
Grey Shield’s Arsenal of Algorithms Include:


Digital Fingerprinting
Advanced Geo Detection services
Pattern Recognition
Bot & Virus Infection Detection
Proxy Network IP Surveillance
Domain Masking Detection

Graceful Interface: Grey Cloak’s API integrates seamlessly into your analytics programs, Programmatic or RTB Networks, and Google, Yahoo, and AOL.


Geo Location Feature: Your ads run specific to the location of the device. For example, as a traveler changes states, his device will adjust your ad accordingly where he might see a different ad or be redirected to another website.

Non-approved States: Screen out non-approved states from specific ad campaigns from showing in states that are not approved for that product.

Target marketing: This functionality also allows you to geographically target your ad compaigns. You can determine a geographical radius corresponding to a store location or desirable zip code market.


AS is 500M PER NVSOS AND THE OS IS 140M as per latest Q filing on 11/15/17

Approximately $160K max in notes remaining with over $500k paid off

RS- REVERSE SPLIT that was approved for anytime before the end of 2017 was CANCELLED per PR from CEO 

To approve an amendment to our Articles of Incorporation to 

effect a reverse stock split of our common stock at a ratio up to 1-for-

100, the exact ratio and timing of which will be set by our Board of

Directors at a future date no later than December 31,2017. 

The agenda item passed with votes as follows: 

For: 10,833,873 
Against: 370,762 
Abstain: 3,100 
Percentage Approving: 63.1% 

EQOVA LIFE SCIENCES Started their business per

NVSOS on AUGUST 1, 2017



Eqova Life Sciences CEO 

Eqova Life Sciences’
Executive Team

Eqova’s management team brings 40 years of experience in the health product space. With sprawling expertise in functional medicine, product formulation, branding, direct sales, health practitioner partnerships and regulation & compliance.

Patrick Stiles

Co-Founder & CEO

Patrick is a serial entrepreneur who has spent most of the last decade working with Ph.D.s the world over to bring to market cutting edge health products that can transform people’s lives.

He is personally responsible for building numerous multi-million-dollar consumer health brands, helping thousands of people form dozens of countries with some of their most pressing health concerns.

He is a health startup veteran and expert in product formulation and health branding.

When Patrick isn’t working tirelessly to further his professional passions, you can find him salsa dancing with his wife, hiking in the Colorado Rockies, traveling internationally, volunteering with incarcerated youths or working on his own health with functional medicine.

Matthew Grabau

Co-Founder & CMO

Matt has grown a several nutraceutical ventures into multi-million-dollar operations from start-up. In his tenure with Eqova, he has been instrumental in operational development from concept to current day, serving a central role in the creation of the company’s proprietary business model, procuring raw material and personnel for start-up, establishing relationships with distributors and sales personnel, securing patented delivery systems and overseeing sales operations.

Previously, Matt was the CEO of Rocky Mountain Pro Nutrients. It was here that he and his team of sales representatives were responsible for growing one of the nation’s premier professional nutraceutical business from inception to $5 million in less than four years. His organization generated an average year-over-year growth of 270%, building towards a monthly volume of over 24,000 units.

Matt holds a Bachelor of Science degree from University of Northern Colorado and enjoys time with his wife and 3 children.

Dr. Paul Dragul

Chief Medical Officer

Dr. Dragul has spent over 4 decades studying and practicing medicine. He’s focused on bringing innovative new techniques and health practices to his patients. His greatest pride is helping people live healthier, happier lives.

He received his Ph.D. with Honors in Pharmacology & M.D. from the University of Cincinnati. He practiced at the United States Public Health Service & as the General Medical Officer for the Indian Hospital in Gallup New Mexico before practicing privately in Colorado.

Jesse Cothran


With over 17 years of experience in the industry, Jesse Cothran is a dietary supplement expert. He has helped numerous companies expand business operations into more than 55 countries internationally and navigate through various federal, state, and foreign regulatory and quality requirements. Having started his career in a call center and eventually working his way up to become an executive, he is known for understanding the industry inside and out and helping companies build multi-million dollar businesses where quality and compliance are an integral part of the corporate culture.


Why Eqova Life Sciences?

Our Mission is to change the health of people the world over with safe, effective and standardized full spectrum hemp oil health products through their trusted professional medical health practitioners.

Cannabinoid Rich Health Supplements are powerful tools. Many people in the general public know this. And demand this benefits for their own health.


Eqova’s Mission & Core Values

Eqova Life Sciences, Inc. is the world’s very first full spectrum hemp oil brand exclusively created for medical practitioners.


Our Mission

is to change the health of people the world over with safe, effective and standardized full spectrum hemp oil health products through their trusted professional medical health practitioners.

Cannabinoid Rich Health Supplements are powerful tools. Many people in the general public know this, and demand these benefits for their own health.

But nothing is more effective than a holistic approach to modern medicine. Incorporating the very best of the western healthcare model with natural solutions when and where appropriate.


Eqova Believes

the most effective and safe application of full spectrum hemp oil health products is under the care and guidance of a medical practitioner.

This may allow regular people to achieve extraordinary health.

Because core regular people can achieve vibrant health without always resulting to prescription drugs or surgeries.

No one knows their patients’ health like the medical professionals who work with them to improve it.




Interactive Brokers Advertisement
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
GRCK News: Current Report Filing (8-k) 11/20/2017 05:07:45 PM
GRCK News: Quarterly Report (10-q) 11/15/2017 05:03:47 PM
GRCK News: Proxy Statement (definitive) (def 14a) 11/15/2017 04:02:44 PM
GRCK News: Notification That Quarterly Report Will Be Submitted Late (nt 10-q) 11/15/2017 01:26:33 PM
GRCK News: Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) 11/03/2017 05:10:33 PM
#11834  Sticky Note introductory video via CEO Patrick Stiles FollowTheProfits 11/27/17 08:11:51 AM
#11352  Sticky Note $GRCK DD, must read Recently acquired, a Clinical-grade KeepItRealistic 11/17/17 11:37:01 PM
#8487  Sticky Note Grey Cloak Tech Clarifies Reverse Split threewheeler 10/26/17 03:27:52 PM
#3515   What MM's are on level 2? thx goarmy2020 10/06/17 12:10:02 PM
#3514   Roger that. Lots stocks run to multi pennies goarmy2020 10/06/17 12:07:01 PM
#3513   A whole lot of dumping here, could be bilrip 10/06/17 12:05:39 PM
#3512   I want to pick up more here Batman412 10/06/17 12:03:41 PM
#3511   Next week will be epic!!!!!!!! What a find!!!! Batman412 10/06/17 12:02:56 PM
#3510   Completely agree. Still the best show in town. One O'Clock Drop 10/06/17 12:01:46 PM
#3509   LOL if you think that is a lot. FollowTheProfits 10/06/17 12:00:18 PM
#3508   Added again, no brainer here. Reading all these King Jimbo 10/06/17 11:59:00 AM
#3507   As long as they stop and let it Adam16 10/06/17 11:56:57 AM
#3506   My lord people, its OK EVEN IF ITS Mr Rollup 10/06/17 11:54:01 AM
#3505   75 mil, wow, no shame. GRCK Maniana 10/06/17 11:52:39 AM
#3504   That post will really encourage buyers. Geez goarmy2020 10/06/17 11:50:53 AM
#3503   Nice. Next week should be fun around here. hydr0gen1 10/06/17 11:50:17 AM
#3502   Wow, stop the dilution! Adam16 10/06/17 11:47:39 AM
#3501   Thx. Very low goarmy2020 10/06/17 11:46:49 AM
#3500   It's 75 million as of yesterday. Via email One O'Clock Drop 10/06/17 11:45:42 AM
#3499   Because they issued shares for the acquisition but FollowTheProfits 10/06/17 11:44:13 AM
#3498   The share count here is tiny. It's been goarmy2020 10/06/17 11:43:48 AM
#3497   Actually, I was thinking those extra shares One O'Clock Drop 10/06/17 11:43:20 AM
#3496   People keep talking about a reverse split. Holy One O'Clock Drop 10/06/17 11:40:23 AM
#3495   411 ? News today ? FINALCUT71 10/06/17 11:39:24 AM
#3494   Insiders are dumping to get paid... Trying to Drugdoctor 10/06/17 11:38:38 AM
#3493   I agree goarmy2020 10/06/17 11:37:24 AM
#3492   I emailed the TA again to verify the One O'Clock Drop 10/06/17 11:35:39 AM
#3491   Yup wish they would have only increased shares, Masala 10/06/17 11:33:23 AM
#3490   Ho lee cow, this is boring. Wake Mr Rollup 10/06/17 11:31:21 AM
#3489   LOL...I think it's giving lots of us heartburn. goarmy2020 10/06/17 11:23:46 AM
#3488  Restored Hey Sporty, was just wondering where this hedge Damascus 10/06/17 11:22:06 AM
#3487   I was thinking that too, but wasn't sure One O'Clock Drop 10/06/17 11:20:40 AM
#3486   Umm,,, yeah, I did. Thank you One O'Clock Drop 10/06/17 11:19:48 AM
#3485   This channel 17-24 is giving me heartburn, Masala 10/06/17 11:19:45 AM
#3484   Thats what it was before, then otc lowered Mr Rollup 10/06/17 11:18:44 AM
#3483   Dude it's not even spelled right. No you Damascus 10/06/17 11:17:34 AM
#3482   Got this from the TA yesterday afternoon One O'Clock Drop 10/06/17 11:16:39 AM
#3481   After the acquisition, which is expected to be RAND 10/06/17 11:12:41 AM
#3480   We won't get it until the merger is dmelvin 10/06/17 10:52:24 AM
#3479   Noticed that too ;-) jackson73 10/06/17 10:52:23 AM
#3478   That's what I was saying...that it's surprising more goarmy2020 10/06/17 10:51:02 AM
#3477   Just saying- NITE is .0224 and CSTI is Damascus 10/06/17 10:46:37 AM
#3476   think so too i_like_bb_stock 10/06/17 10:41:00 AM
#3475   MM's will let this go soon. The Apostle 10/06/17 10:40:35 AM
#3474   Hmmm. Maybe the buy on the rumor peeps goarmy2020 10/06/17 10:39:20 AM
#3473   PUMA that dirty cat. Mr Rollup 10/06/17 10:38:58 AM
#3472   all you ever talk about on every board Dvanajscak 10/06/17 10:38:54 AM
#3471   OR start to rise knowing news is coming. goarmy2020 10/06/17 10:36:41 AM
#3470   it will drop below .015. If no news Stock Predictor 10/06/17 10:35:05 AM
#3469   Gobbled some 17s i_like_bb_stock 10/06/17 10:34:27 AM
#3468   Bull flag and strong base here. Mr Rollup 10/06/17 10:31:47 AM
#3467   PUMA. Cover and collect esi23 10/06/17 10:31:42 AM
#3466   NEW: EQOVA job postings all over U.S! Adam16 10/06/17 10:31:35 AM